Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

C3_BILIARY_GALLBLADDER

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cause of death: ICD-10 — C22, C23&, C24 Cause of death: ICD-9 — 155\|156 Cause of death: ICD-8 — 155\|156 Cancer registry: Topography ICD-O-3 — C2[2-4] Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 2 out of 7 registries used, show all original rules.	2422
4. Check minimum number of events None	2422
5. Include endpoints C3_LIVER_INTRAHEPATIC_BILE_DUCTS C3_GALLBLADDER C3_BILIARY_TRACT	2422
6. Filter based on genotype QC (FinnGen only)	2152

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF9

NAME	C3_BILIARY_GALLBLADDER
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	C3_LIVER_INTRAHEPATIC_BILE_DUCTS\|C3_GALLBLADDER\|C3_BILIARY_TRACT
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C2[2-4]
COD_ICD_9	155\|156
COD_ICD_8	155\|156
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C2[2-4]
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2152	694	1458
Unadjusted period prevalence (%)	0.53	0.25	0.67
Median age at first event (years)	72.67	72.60	72.71

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2230: Matched controls
22299

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JN4BD

NOMESCO Finland

Extensive body CT

9.9

323.0

409

495

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

25.0

323.0

232

103

L01BC06

ATC

capecitabine; oral

+∞

323.0

302

R18

ICD-10 Finland

Ascites

21.4

316.2

243

127

H02AB02

ATC

dexamethasone; systemic

59.7

307.7

509

110

A04AA01

ATC

ondansetron; systemic, rectal

20.1

307.7

347

203

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

22.8

307.7

268

133

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

20.8

307.7

269

146

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

10.2

307.7

641

847

WX302

NOMESCO Finland

Thoracal epidural anesthesy

22.3

307.7

336

176

Z51.5

ICD-10 Finland

Palliative care

27.0

307.7

961

609

A03FA01

ATC

metoclopramide; systemic, rectal

14.4

307.7

1025

1246

JN4AD

NOMESCO Finland

Body CT examination

11.5

307.7

621

722

K83.1

ICD-10 Finland

Obstruction of bile duct

58.3

307.7

316

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

307.7

304

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

30.8

307.7

274

101

JN4CD

NOMESCO Finland

Very extensive body CT

30.5

307.7

311

118

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

1135

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

154.4

307.7

671

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

307.7

677

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

307.7

966

A04AA02

ATC

granisetron; systemic, transdermal

1185.9

307.7

392

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

67.7

307.7

258

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

5718.8

307.7

468

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3700.3

307.7

329

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

31.6

307.7

225

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

120.3

307.7

600

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

307.7

426

N02AA05

ATC

oxycodone; systemic

8.9

307.7

1117

2263

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

31.1

307.7

286

105

UJK02

NOMESCO Finland

ERCP

17.1

307.7

364

252

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

22.2

307.6

232

116

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

12.0

296.1

318

305

K83.0

ICD-10 Finland

Cholangitis

20.7

296.0

230

123

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

+∞

290.1

272

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

128.2

285.1

144

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

26.8

268.6

187

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

267.2

251

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

17.4

261.8

221

140

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

19.1

260.6

210

121

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

+∞

247.6

233

198

Kela drug reimbursment

Sorafenib

+∞

242.2

228

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

18.1

241.4

199

120

JN3AD

NOMESCO Finland

Abdominal CT examination

5.2

230.5

576

1389

8160/3-C22.1

ICD-O-3

Cholangiocarcinoma of intrahepatic bile duct

+∞

229.2

216

WF002

NOMESCO Finland

Radical radiotherapy

85.2

228.8

121

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

5.1

226.8

591

1475

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

610.2

226.7

221

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

7.2

220.2

363

589

C23

ICD-10 Finland

Malignant neoplasm of gallbladder

+∞

218.4

206

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

14.5

214.0

199

150

WZC00

NOMESCO Finland

Treatment plan or consultation

3.9

207.0

953

3601

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

10.4

193.4

225

239

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

21.0

186.0

142

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

12.9

179.4

178

149

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

168.9

160

C61

ICD-10 Finland

Malignant neoplasm of prostate

354.8

166.5

166

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

6.9

160.7

265

426

JLC30

NOMESCO Finland

Pancreatoduodenectomy

824.9

158.5

154

WW500

NOMESCO Finland

Blood transfusion

10.5

151.6

173

178

A06AH03

ATC

naloxegol; oral

28.5

149.6

101

XX3DW

NOMESCO Finland

Time consuming IT work

6.5

145.7

256

438

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

63.8

144.6

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

32.7

140.9

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

20.9

139.4

106

C24.0

ICD-10 Finland

Malignant neoplasm: Extrahepatic bile duct

+∞

138.0

131

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

33.9

137.8

A05AA02

ATC

ursodeoxycholic acid; oral

16.6

131.7

112

WZC30

NOMESCO Finland

Teaching

3.8

131.0

478

1489

L01XE05

ATC

[U] sorafenib

+∞

130.5

124

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

130.5

124

323

Kela drug reimbursment

Sorafenib

+∞

129.4

123

WF049

NOMESCO Finland

Radiotherapy of metastasis

1288.9

126.3

122

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

25.0

125.9

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

31.5

125.6

8140/3-C23.9

ICD-O-3

Adenocarcinoma, NOS, of gallbladder

+∞

124.1

118

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.3

122.3

363

973

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

1244.2

122.1

118

8160/3-C24.9

ICD-O-3

Cholangiocarcinoma of billiary tract, NOS

+∞

120.9

115

127

Kela drug reimbursment

Transplant complication

16.2

117.7

101

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

38.6

115.2

C24.1

ICD-10 Finland

Malignant neoplasm: Ampulla of Vater

+∞

114.6

109

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

112.4

107

C24.09

ICD-10 Finland

Biliary duct or passage NOS

+∞

109.3

104

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.4

109.1

471

1623

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

+∞

108.2

103

A04AA55

ATC

palonosetron, combinations; systemic

+∞

106.1

101

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

41.2

105.6

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

37.2

104.5

JAH01

NOMESCO Finland

Laparoscopy

7.7

104.2

150

206

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

25.1

103.5

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

+∞

102.9

B01AB10

ATC

tinzaparin; parenteral

4.1

102.6

318

875

8000/3-C24.9

ICD-O-3

Neoplasm, malignant of billiary tract, NOS

+∞

100.8

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

39.2

99.4

D77

ICPC

Malignant digestive neopl other/NOS

509.9

99.3

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

957.8

94.6

116

Kela drug reimbursment

Prostate cancer

+∞

93.4

C24.00

ICD-10 Finland

Hepatic duct

+∞

92.3

Z94.4

ICD-10 Finland

Liver transplant status

115.1

91.7

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

91.7

870

4514

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

90.2

C24.02

ICD-10 Finland

Common bile duct

+∞

89.2

I81

ICD-10 Finland

Portal vein thrombosis

28.0

88.5

R50.9

ICD-10 Finland

Fever, unspecified

3.0

88.4

470

1814

8140/3-C24.1

ICD-O-3

Adenocarcinoma, NOS, of ampulla of Vater

+∞

88.1

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

87.2

643

2945

A07AA11

ATC

rifaximin; oral

35.2

87.1

L04AD02

ATC

tacrolimus; systemic

17.3

86.9

UJK12

NOMESCO Finland

Peroral cholangioscopy

47.4

86.9

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

36.9

86.6

C03DA01

ATC

spironolactone; oral

2.8

86.4

536

2247

8000/3-C80.9

ICD-O-3

Neoplasm, malignant of unknown primary site

+∞

86.0

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

135.5

85.6

R4190

NOMESCO Finland

Nutritional therapy

7.3

85.2

128

184

TPH07

NOMESCO Finland

Cathetrisation of artery

3.2

85.1

392

1390

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

+∞

84.9

L03AA02

ATC

filgrastim; parenteral

154.4

84.7

A06AD11

ATC

lactulose; oral

2.7

83.3

596

2681

L01EX02

ATC

sorafenib; oral

+∞

82.8

WX402

NOMESCO Finland

General anaesthesia

2.8

82.7

496

2038

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

827.9

82.0

JJC00

NOMESCO Finland

Allogenic transplantation of liver

172.3

79.6

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

16.4

78.9

C24.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of biliary tract

+∞

78.6

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

78.6

B01AB05

ATC

enoxaparin; parenteral

2.4

78.0

783

4107

3019

Kela drug reimbursment

Lenvatinib

+∞

76.5

WPB10

NOMESCO Finland

Making a convalescent care decision

45.9

76.1

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

763.5

75.7

L04AA06

ATC

mycophenolic acid; systemic

8.9

75.2

111

1508

Kela drug reimbursment

Lenvatinib

+∞

74.4

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

23.0

74.1

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

11.3

73.9

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

72.3

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

17.5

70.6

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

16.8

70.4

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

70.2

J01MA12

ATC

levofloxacin; systemic

2.5

70.1

554

2589

K76.9

ICD-10 Finland

Liver disease, unspecified

9.3

69.6

A79

ICPC

Malignancy NOS

150.9

69.4

8160/3-C24.0

ICD-O-3

Cholangiocarcinoma of extrahepatic bile duct

+∞

68.1

N02AX02

ATC

tramadol; systemic, rectal

2.2

67.5

1077

6737

L01EX08

ATC

lenvatinib; oral

+∞

66.0

JAH00

NOMESCO Finland

Laparotomy

6.0

65.2

119

209

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

331.4

64.8

ZX120

NOMESCO Finland

Intravenous

3.4

64.8

249

784

L03AA13

ATC

pegfilgrastim; parenteral

326.1

63.8

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.3

62.7

172

428

8000/3-C22.1

ICD-O-3

Neoplasm, malignant of intrahepatic bile duct

+∞

61.7

TPX10

NOMESCO Finland

Implantation of vascular injection port

6.4

60.8

103

168

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

27.8

60.3

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

111.6

60.1

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

5.4

59.0

120

233

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

205.4

58.3

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

57.6

557

2817

8140/3-C24.0

ICD-O-3

Adenocarcinoma, NOS, of extrahepatic bile duct

+∞

57.5

JK3FT

NOMESCO Finland

Exchange of bile duct catheter with radiological guidance

299.6

57.5

JKA20

NOMESCO Finland

Cholecystectomy

4.8

57.0

133

291

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

55.8

1193

8115

D70.82

ICD-10 Finland

Drug-induced neutropenia

20.4

54.8

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

12.0

54.2

JJB30

NOMESCO Finland

Excision of two segments of liver

540.7

53.7

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

7.8

52.4

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

52.3

N02AA01

ATC

morphine; systemic, rectal

6.4

52.0

140

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

51.2

A02BC02

ATC

pantoprazole; systemic

2.0

50.7

1525

11516

B01AB04

ATC

dalteparin; parenteral

3.8

50.3

162

452

L02AE02

ATC

leuprorelin; implant, parenteral

72.9

50.3

WF004

NOMESCO Finland

Palliative radiotherapy

498.7

49.6

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.0

49.6

149

396

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

11.6

49.2

A04AD12

ATC

aprepitant; systemic

+∞

49.1

B18.2

ICD-10 Finland

Chronic viral hepatitis C

11.9

49.0

103

Kela drug reimbursment

Diabetes, insulin-treated

2.0

48.6

860

5404

D97

ICPC

Liver disease NOS

14.6

47.7

115

Kela drug reimbursment

Breast cancer

+∞

47.0

176

Kela drug reimbursment

Regorafenib

+∞

47.0

D13.4

ICD-10 Finland

Benign neoplasm: Liver

17.6

46.3

PJA12

NOMESCO Finland

Sentinel node biopsy

456.8

45.4

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

10.9

44.5

A10AB05

ATC

insulin aspart; parenteral

2.7

44.1

263

1055

R4110

NOMESCO Finland

Physiotherapy

2.0

44.0

632

3671

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

120.0

43.9

8000/3-C24.0

ICD-O-3

Neoplasm, malignant of extrahepatic bile duct

+∞

43.9

WX004

NOMESCO Finland

Patient-controlled sedation

17.4

43.7

WW200, ,

SPAT

0.4

43.5

192

4684

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

435.9

43.3

JJB10

NOMESCO Finland

Atypcal resection of liver

+∞

42.8

A10AE04

ATC

insulin glargine; parenteral

2.4

42.5

330

1501

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.4

42.3

163

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

41.8

8140/3-C24.9

ICD-O-3

Adenocarcinoma, NOS, of billiary tract, NOS

+∞

41.8

C03CA01

ATC

furosemide; systemic

1.8

41.6

1025

7069

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

5.5

41.0

153

C22.7

ICD-10 Finland

Malignant neoplasm: Other specified carcinomas of liver

+∞

40.7

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

404.6

40.2

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

109.6

39.8

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.9

39.8

123

333

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

4.7

39.6

204

K92.0

ICD-10 Finland

Haematemesis

4.0

39.4

115

299

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

14.1

39.1

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

203.5

38.9

TJA10

NOMESCO Finland

Laparocentesis

139.2

38.8

PC2SC

NOMESCO Finland

Liver angiography with X-ray

383.8

38.1

JJA20

NOMESCO Finland

Open biopsy of liver

72.9

38.0

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

135.7

37.8

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

37.7

767

4950

369

Kela drug reimbursment

Regorafenib

+∞

37.6

KCD02

NOMESCO Finland

Transurethral resection of bladder

10.7

37.6

A10BA02

ATC

metformin; oral

1.8

37.4

842

5602

C22

ICD-10 Finland

Malignant neoplasm of liver and intrahepatic bile ducts

+∞

36.6

JK3NT

NOMESCO Finland

Percutaneous transhepatic dilatation of bileducts

81.5

35.9

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.3

35.9

141

3686

SPAT1109

SPAT

Analgesia with portable analgesic pump

13.9

35.7

UJF32

NOMESCO Finland

Coloscopy

1.9

35.6

603

3661

J01MA02

ATC

ciprofloxacin; systemic

1.8

35.5

927

6414

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

35.4

667

4187

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

12.2

35.1

ZXE20

NOMESCO Finland

More than three and less than five hours

2.2

35.0

328

1609

XX2RW, ,

NOMESCO Finland

11.0

34.7

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

34.5

8000/3-C23.9

ICD-O-3

Neoplasm, malignant of gallbladder

+∞

34.5

L04AD01

ATC

ciclosporin; systemic

6.3

34.4

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

34.2

497

2864

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.1

33.7

398

2131

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

33.4

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

33.4

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

33.4

352

1806

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

331.9

33.0

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

331.9

33.0

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

331.9

33.0

L02BB03

ATC

bicalutamide; oral

+∞

32.4

L01EX05

ATC

regorafenib; oral

+∞

31.3

WF003

NOMESCO Finland

Adjuvant radiotherapy

162.2

30.7

SPAT1262

SPAT

Handing over of treatment supplies

1.9

30.7

466

2714

A41.8

ICD-10 Finland

Other specified sepsis

4.0

30.3

219

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

30.3

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

+∞

30.3

WVA20

NOMESCO Finland

Medicine administration

4.1

30.1

207

Y77

ICPC

Malignant neoplasm prostate

83.8

29.8

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

29.2

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

29.2

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

7.6

28.9

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

285.0

27.8

JJB71

NOMESCO Finland

Laparoscopic resection of liver

285.0

27.8

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

26.9

385

2191

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

141.7

26.7

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.9

26.5

120

ZX090

NOMESCO Finland

Other technic of radiotherapy

46.3

26.5

T90

ICPC

Diabetes non-insulin dependent

1.7

26.4

654

4378

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

26.1

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

263.6

25.7

C10AA07

ATC

rosuvastatin; oral

0.5

25.1

325

5464

JJA44

NOMESCO Finland

Laparoscopic destruction of lesion of liver

+∞

25.0

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

25.0

A10BH01

ATC

sitagliptin; oral

2.0

24.9

286

1506

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

252.9

24.7

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

252.9

24.7

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

24.7

688

4733

K85.8

ICD-10 Finland

Other acute pancreatitis

7.5

24.6

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.8

24.6

120

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

27.9

24.5

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

6.3

24.5

WX002

NOMESCO Finland

Sedation and analgesia

1.8

24.4

423

2550

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

48.9

24.3

A10BB12

ATC

glimepiride; oral

2.1

24.1

266

1379

9680/3-C22.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of liver

+∞

24.0

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

+∞

24.0

ZZR00

NOMESCO Finland

Flap of skin

8.7

23.7

WX892

NOMESCO Finland

Monitored bed care

2.2

23.6

202

949

K75.0

ICD-10 Finland

Abscess of liver

19.7

23.5

C10AX09

ATC

ezetimibe; oral

0.4

23.2

120

2829

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

23.0

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

23.0

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

+∞

23.0

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

7.2

22.9

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.5

22.7

124

ZX070

NOMESCO Finland

Intensity modified radiotherapy

121.3

22.6

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

32.6

22.4

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

4.1

22.4

155

K72.1

ICD-10 Finland

Chronic hepatic failure

24.1

22.2

C24.01

ICD-10 Finland

Cystic duct

+∞

21.9

8140/3-C80.9

ICD-O-3

Adenocarcinoma, NOS, of unknown primary site

+∞

21.9

L02BG04

ATC

letrozole; oral

29.4

21.9

HAC20

NOMESCO Finland

Total mastectomy

80.9

21.7

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

4.0

21.7

159

JJ5AT, ,

NOMESCO Finland

222.1

21.6

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

116.2

21.6

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

5.1

21.4

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.7

21.1

117

450

EB1VA, ,

NOMESCO Finland

0.3

21.0

2017

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

20.9

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

20.9

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

+∞

20.9

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

20.9

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

3.0

20.8

318

HAB40

NOMESCO Finland

Wedge excision of mammary gland

19.6

20.8

ZX050

NOMESCO Finland

Stereotactic radiotherapy

42.1

20.5

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

42.1

20.5

A10BX07

ATC

[U] liraglutide

4.5

20.4

110

TK800

NOMESCO Finland

Hemodialysis

3.6

20.3

190

160

Kela drug reimbursment

exenatide

3.6

20.2

186

N06DX01

ATC

memantine; oral

0.3

20.1

1874

B03XA02

ATC

darbepoetin alfa; parenteral

4.1

20.0

137

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

7.7

20.0

N05CF01

ATC

zopiclone; oral

1.6

20.0

719

5207

JKC30

NOMESCO Finland

Partial excision of bile duct and anastomosis to jejunum

+∞

19.8

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

19.8

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

19.8

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

+∞

19.8

WX882

NOMESCO Finland

High dependency care

3.1

19.7

264

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

74.2

19.7

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

201.7

19.6

ZXE00

NOMESCO Finland

One hour or less

1.6

19.5

721

5245

ZX108

NOMESCO Finland

Inhalation

7.4

19.5

XW000

NOMESCO Finland

Bone marrow biopsy

3.2

19.4

241

A41.9

ICD-10 Finland

Sepsis, unspecified

2.6

19.3

116

464

A10AE05

ATC

insulin detemir; parenteral

2.3

19.0

150

680

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

6.2

18.9

C10AA05

ATC

atorvastatin; oral

0.6

18.8

616

8321

SPAT1255

SPAT

Intravenous administration of medicine

2.2

18.8

174

842

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

18.8

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

18.8

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

18.8

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.6

18.6

112

449

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

191.5

18.6

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.0

18.4

291

AA1BD

NOMESCO Finland

Extensive CT of head and brain

4.0

18.3

133

JN6AD

NOMESCO Finland

CT of torso and neck

6.9

18.3

K72.9

ICD-10 Finland

Hepatic failure, unspecified

6.3

18.0

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

5.1

17.9

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.7

17.8

358

PG1PT

NOMESCO Finland

Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified

7.6

17.8

JFB30

NOMESCO Finland

Right hemicolectomy

7.3

17.8

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.8

17.8

319

JDE00

NOMESCO Finland

Gastrojejunostomy

67.1

17.7

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

67.1

17.7

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

17.7

1550A

ICD-9 Finland

Malignant neoplasm of liver and intrahepatic bile ducts, Liver, primary

+∞

17.7

L01XE21

ATC

[U] regorafenib

+∞

17.7

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

17.7

D76

ICPC

Malignant neoplasm pancreas

95.8

17.6

K70.4

ICD-10 Finland

Alcoholic hepatic failure

7.4

17.4

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

3.1

17.2

243

WPA13

NOMESCO Finland

Palliative consultation

14.9

17.1

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

5.8

17.1

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

17.1

278

1633

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.1

17.0

159

773

K92.1

ICD-10 Finland

Melaena

2.1

17.0

159

773

XX4BW, ,

NOMESCO Finland

25.8

16.9

A98

ICPC

Health maint/preventive medicine

0.7

16.9

1559

17370

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

16.7

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

16.7

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

16.7

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

16.7

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

16.7

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

16.7

8140/3-C22.1

ICD-O-3

Adenocarcinoma, NOS, of intrahepatic bile duct

+∞

16.7

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.7

16.7

336

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

16.6

253

1456

K51.5

ICD-10 Finland

Left sided colitis

3.3

16.6

191

P20

ICPC

Memory disturbance

0.5

16.6

163

3048

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.6

16.5

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

16.3

302

1842

A10AC01

ATC

insulin (human); parenteral

1.9

16.2

226

1265

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

16.1

200

1077

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

16.1

402

2652

HA1AA

NOMESCO Finland

X-ray mammography

3.3

16.0

185

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.3

15.9

191

162

Kela drug reimbursment

liraglutide

4.2

15.8

EB4VA, ,

NOMESCO Finland

0.3

15.7

1435

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

+∞

15.6

8140/3-C22.0

ICD-O-3

Adenocarcinoma, NOS, of liver

+∞

15.6

JK3SB

NOMESCO Finland

Endoscopic retrorade cholangiography

17.3

15.6

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.6

15.5

372

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

15.3

322

2030

K70.1

ICD-10 Finland

Alcoholic hepatitis

5.5

15.3

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

15.2

163

834

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

15.2

391

5637

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

15.0

296

RS220, ,

NOMESCO Finland

4.8

15.0

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

15.1

14.9

JJA43

NOMESCO Finland

Destruction of lesion of liver

+∞

14.6

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

14.6

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

+∞

14.6

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

3.5

14.6

141

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.8

14.6

229

1329

PJD99

NOMESCO Finland

Excision of other lymph nodes

151.0

14.5

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

14.3

137

673

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

6.2

14.2

WX704

NOMESCO Finland

Intubation

2.0

14.0

147

746

Z76.0

ICD-10 Finland

Issue of repeat prescription

0.6

14.0

205

3413

WPA43, ,

SPAT

30.2

13.9

205

Kela drug reimbursment

Chronic hypertension

1.4

13.9

773

6018

K81.0

ICD-10 Finland

Acute cholecystitis

2.8

13.8

263

R4110, ,

SPAT

0.4

13.8

1796

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.4

13.7

1487

ZXD05

NOMESCO Finland

Urgent procedure

1.5

13.7

597

4432

L04AX01

ATC

azathioprine; systemic

2.5

13.7

358

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

13.7

126

609

J94.8

ICD-10 Finland

Other specified pleural conditions

3.5

13.6

138

L02BA01

ATC

tamoxifen; oral

75.6

13.6

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

75.6

13.6

L01XE29

ATC

[U] lenvatinib

+∞

13.6

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

13.6

C50.99

ICD-10 Finland

Breast, unspecified

140.8

13.5

NK6AN

NOMESCO Finland

Total body bone isotope imaging

16.3

13.4

ZXC40

NOMESCO Finland

Use of ultrasound

11.5

13.3

C07AG02

ATC

carvedilol; oral

1.9

13.2

174

955

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.7

13.2

112

H02AB06

ATC

prednisolone; systemic

1.4

13.2

948

7700

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

13.1

622

4688

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.1

13.1

125

612

N05AX08

ATC

risperidone; systemic

0.4

13.1

1579

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

13.0

200

3294

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.7

13.0

249

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

16.8

13.0

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

28.5

13.0

A10BG03

ATC

pioglitazone; oral

2.6

12.9

308

JLB28

NOMESCO Finland

Endoscopic internal drainage of pancreatic duct

22.7

12.9

XQ902

NOMESCO Finland

Other photography

4.1

12.8

Z2446

NOMESCO Finland

Social worker

2.1

12.8

116

558

WZC00, ,

SPAT

0.5

12.6

1921

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

15.5

12.6

L04AA10

ATC

[U] sirolimus

70.3

12.6

E0000UV, ,

ATC

1.4

12.5

756

5944

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

4.2

12.5

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

12.5

L02AE04

ATC

triptorelin; parenteral

+∞

12.5

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

12.5

YJ3VG

NOMESCO Finland

MRI examination of abdomen with high intesity magnet for dose design of radiotherapy

+∞

12.5

JJB20

NOMESCO Finland

Excision of single segment of liver

+∞

12.5

1552X

ICD-9 Finland

Malignant neoplasm of liver and intrahepatic bile ducts, Liver, not specified as primary or secondary[NEOPLASMA MALIGNUMHEPATIS, NON DEFINITUM PRIM/SEC]

+∞

12.5

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

12.5

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

12.5

8010/3-C22.0

ICD-O-3

Carcinoma, NOS, of liver

+∞

12.5

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

12.5

JJB53

NOMESCO Finland

Excision of segments IV,V, VI, VII and VIII of liver

+∞

12.5

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

12.5

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.3

12.5

425

WPA11

NOMESCO Finland

Developing a plan for palliative care

20.1

12.5

Z51.0

ICD-10 Finland

Radiotherapy session

130.7

12.4

X76

ICPC

Malignant neoplasm breast female

130.7

12.4

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

11.7

12.3

Z3231

NOMESCO Finland

Registered nurse

1.5

12.3

503

3679

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.4

12.2

347

WPA41

NOMESCO Finland

Psychosocial conversational support in palliative care

37.8

12.2

A10BX04

ATC

[U] exenatide

4.0

12.2

Z2221

NOMESCO Finland

Medical doctor

1.5

12.1

461

3322

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

12.0

695

5414

WPA44

NOMESCO Finland

Nursing home for palliative care

21.4

12.0

R10.0

ICD-10 Finland

Acute abdomen

2.6

11.9

272

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

11.9

107

512

C10AC01

ATC

colestyramine; oral

2.8

11.8

210

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.3

11.7

386

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

12.6

11.6

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

65.3

11.6

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

65.3

11.6

XF612

NOMESCO Finland

Measurement of central venous pressure

23.0

11.6

N02AA03

ATC

hydromorphone; systemic, rectal

23.0

11.6

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.7

11.6

428

5791

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

11.5

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

11.5

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

11.5

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

11.5

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

11.5

C22.2

ICD-10 Finland

Malignant neoplasm: Hepatoblastoma

+∞

11.5

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

11.5

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

11.5

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

120.6

11.4

Z3226

NOMESCO Finland

Physiotherapist

1.6

11.4

333

2267

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.4

11.3

304

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.3

11.3

360

JK3MB

NOMESCO Finland

Postoperative cholangiography

35.2

11.3

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

12.8

11.1

K76.7

ICD-10 Finland

Hepatorenal syndrome

13.9

11.0

WX419

NOMESCO Finland

Other general anesthesy

4.5

11.0

K76.89

ICD-10 Finland

Other specified diseases of liver

15.6

10.8

R11

ICD-10 Finland

Nausea and vomiting

1.8

10.8

163

934

PC1BC

NOMESCO Finland

Extensive angiography of aorta and abdominal arteries

8.3

10.8

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

28.2

10.7

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

0.7

10.7

315

4468

N06DA02

ATC

donepezil; oral

0.4

10.7

1372

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

60.3

10.6

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

10.6

187

1121

M04AA01

ATC

allopurinol; systemic

1.5

10.6

350

2444

TDA90, ,

SPAT

0.3

10.6

1013

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

11.3

10.5

C82.1

ICD-10 Finland

Follicular lymphoma grade II

110.5

10.4

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

110.5

10.4

C90.0

ICD-10 Finland

Multiple myeloma

+∞

10.4

L01BC04

ATC

carmofur; oral

+∞

10.4

JK5ZT

NOMESCO Finland

Implantation of bile duct prosthesis with combined percutaneous transhepatic and endoscopic retrograde technic

+∞

10.4

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

10.4

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

10.4

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

10.4

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

10.4

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.7

10.4

182

1089

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

16.1

10.3

D69.5

ICD-10 Finland

Secondary thrombocytopenia

16.1

10.3

WPA44, ,

SPAT

9.6

10.2

D13

ICPC

Jaundice

23.5

10.2

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

10.1

121

644

P01AB01

ATC

metronidazole; oral, rectal

1.4

10.1

661

5232

D70.89

ICD-10 Finland

Neutropenic splenomegaly

5.0

10.0

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

8.5

10.0

A07EC02

ATC

mesalazine; oral, rectal

2.1

10.0

459

WZC15, ,

NOMESCO Finland

20.1

9.8

L15

ICPC

Knee symptom/complaint

0.6

9.8

233

3468

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.4

9.7

101

A10BJ02

ATC

liraglutide; parenteral

2.5

9.7

239

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.0

9.7

107

555

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

55.2

9.6

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

7.8

9.6

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

9.5

132

737

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

9.5

475

K74.3

ICD-10 Finland

Primary biliary cirrhosis

7.2

9.5

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.7

9.4

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

100.5

9.4

JJ2CT

NOMESCO Finland

Biopsy of liver with CT guidance

100.5

9.4

L04AH02

ATC

everolimus; oral

100.5

9.4

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.6

9.4

213

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

9.4

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

9.4

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

9.4

ZX020

NOMESCO Finland

HDR radiotherapy within tissue

+∞

9.4

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

9.4

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

9.4

8140/3-C26.9

ICD-O-3

Adenocarcinoma, NOS, of gastrointestinal tract, NOS

+∞

9.4

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

+∞

9.4

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

9.4

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

9.4

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

9.4

YJ1CD

NOMESCO Finland

Very extensive CT examination of abdomen for dose design of radiotherapy

+∞

9.4

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

9.4

L03

ICPC

Low back symptom/complaint

0.7

9.4

260

3749

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

21.8

9.3

JLB12

NOMESCO Finland

Transduodenal endoscopic incision of pancreatic duct orifice

21.8

9.3

A07AA09

ATC

vancomycin; oral

3.1

9.3

119

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

9.3

111

590

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

9.3

228

3377

SPAT1110

SPAT

Measurement of pain intensity

4.7

9.3

B01AF01

ATC

rivaroxaban; oral

0.6

9.2

120

2082

M79.6

ICD-10 Finland

Pain in limb

0.7

9.2

497

6349

G93.4

ICD-10 Finland

Encephalopathy, unspecified

7.8

9.1

R01AD59

ATC

mometasone, combinations; nasal

0.2

9.1

442

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

36.8

9.0

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

4.1

9.0

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

24.1

8.9

KC1GB

NOMESCO Finland

Cystography with X-ray

24.1

8.9

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

8.8

173

1070

K51.8

ICD-10 Finland

Other ulcerative colitis

3.4

8.8

TPX15

NOMESCO Finland

Removal of vascular injection port

14.1

8.7

I85

ICD-10 Finland

Oesophageal varices

50.2

8.7

WPA43

NOMESCO Finland

A doctor's home visit to perform palliative care

50.2

8.7

ZZA00

NOMESCO Finland

Split skin graft

2.5

8.7

222

A10BH05

ATC

linagliptin; oral

1.8

8.6

139

813

ZX112

NOMESCO Finland

Subcutaneous

4.4

8.6

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

3.1

8.6

115

C07AA05

ATC

propranolol; systemic

1.5

8.5

305

2161

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.4

8.5

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

8.5

203

3026

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.7

8.4

160

L04AA18

ATC

[U] everolimus

90.4

8.4

C20

ICD-10 Finland

Malignant neoplasm of rectum

90.4

8.4

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

90.4

8.4

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

90.4

8.4

SPAT1122

SPAT

Ascites puncture

90.4

8.4

JHA00

NOMESCO Finland

Anal or perianal incision

3.6

8.4

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

8.4

136

797

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.1

8.4

347

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

12.8

8.4

K70.0

ICD-10 Finland

Alcoholic fatty liver

3.4

8.4

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

8.3

8010/3-C23.9

ICD-O-3

Carcinoma, NOS, of gallbladder

+∞

8.3

1551A

ICD-9 Finland

Malignant neoplasm of liver and intrahepatic bile ducts, Intrahepatic bile ducts

+∞

8.3

L01CB01

ATC

etoposide; systemic

+∞

8.3

KCC10

NOMESCO Finland

Cystoprostatectomy

+∞

8.3

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

8.3

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

8.3

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

8.3

C22.3

ICD-10 Finland

Malignant neoplasm: Angiosarcoma of liver

+∞

8.3

128

Kela drug reimbursment

Cancers of female genital organs

+∞

8.3

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

8.3

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

8.3

C25.7

ICD-10 Finland

Malignant neoplasm: Other parts of pancreas

+∞

8.3

C25

ICD-10 Finland

Malignant neoplasm of pancreas

+∞

8.3

TQW20

NOMESCO Finland

Tatoe

+∞

8.3

C22.4

ICD-10 Finland

Malignant neoplasm: Other sarcomas of liver

+∞

8.3

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

8.3

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

8.3

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

8.3

L02BX02

ATC

degarelix; parenteral

+∞

8.3

8246/3-C80.9

ICD-O-3

Neuroendocrine carcinoma, NOS, of unknown primary site

+∞

8.3

YX9AW, ,

NOMESCO Finland

+∞

8.3

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

8.3

115

643

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

8.6

8.3

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

3.1

8.3

112

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

8.3

108

593

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

8.3

618

4964

ZXC96

NOMESCO Finland

Robot assisted procedure

7.1

8.2

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.7

8.2

453

5789

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

0.5

8.2

1515

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.7

8.2

151

JFF10

NOMESCO Finland

Loop enterostomy

14.5

8.2

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

0.6

8.2

161

2511

OAB43, ,

SPAT

0.5

8.2

1358

R01AD58

ATC

fluticasone, combinations; nasal

0.6

8.2

141

2271

OAB42, ,

SPAT

0.5

8.2

1654

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

6.5

8.2

K50.8

ICD-10 Finland

Other Crohn disease

3.6

8.1

H02

ICPC

Hearing complaint

0.6

8.1

162

2516

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

8.1

581

4636

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

8.1

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

11.7

8.1

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

4.0

8.1

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

0.5

8.1

100

1760

F03

ICD-10 Finland

Unspecified dementia

0.4

8.1

1028

N06DA03

ATC

rivastigmine; oral, transdermal

0.4

8.0

929

PC1CC

NOMESCO Finland

Very extensive angiography of aorta and abdominal arteries

8.9

8.0

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.9

8.0

125

JJ1AT

NOMESCO Finland

Puncture of lesion of liver with ultrasound guidance

22.1

8.0

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.7

7.9

154

SPAT1269

SPAT

Other puncture and/or drainage

6.6

7.9

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

13.1

7.9

WX610

NOMESCO Finland

Patient controlled analgesia

7.8

7.9

WZC30, ,

SPAT

0.5

7.8

1165

ZXE70

NOMESCO Finland

Moren than 15 and less than 18 hours

8.5

7.8

R83

ICPC

Respiratory infection other

0.6

7.8

127

2075

OAA67, ,

SPAT

0.4

7.8

858

UJK52

NOMESCO Finland

Endoscopy of biliary tract in connection with endoscopic retrograde cholangiopancreatography

45.1

7.7

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

45.1

7.7

ZX121

NOMESCO Finland

Central venous catheter

15.1

7.7

SPAT1111

SPAT

Planning of analgesia

3.1

7.7

101

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.0

7.6

415

GD1AA, ,

SPAT

0.5

7.6

1442

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

7.6

191

1255

K70.2

ICD-10 Finland

Alcoholic fibrosis and sclerosis of liver

11.9

7.6

JX1XE

NOMESCO Finland

Other ultrasound examinaton of alimentary organs

25.1

7.6

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

7.5

148

915

M25.5

ICD-10 Finland

Pain in joint

0.7

7.5

301

4066

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

7.5

210

1412

K74.0

ICD-10 Finland

Hepatic fibrosis

10.1

7.5

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

7.1

7.5

J01DB01

ATC

cefalexin; oral

1.3

7.4

1541

14094

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

80.4

7.4

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

80.4

7.4

V03AF03

ATC

calcium folinate; systemic

80.4

7.4

SDA01

NOMESCO Finland

Periodontal treatment, very brief

0.7

7.4

221

3152

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.7

7.4

375

4870

J01FF01

ATC

clindamycin; systemic

1.4

7.4

476

3730

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

6.0

7.4

SPAT1053

SPAT

Memory test

0.7

7.4

197

2873

NG1AA, ,

SPAT

0.3

7.3

598

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

8.4

7.3

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

7.3

234

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

7.3

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

7.3

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

7.3

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

7.3

PHN73

NOMESCO Finland

Reconstruction of superior mesenteric or portal vein

+∞

7.3

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

7.3

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

7.3

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

7.3

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

7.3

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

+∞

7.3

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

7.3

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

7.3

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

7.3

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

7.3

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

7.3

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

7.3

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

9.4

7.3

L08

ICPC

Shoulder symptom/complaint

0.7

7.3

226

3199

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

0.5

7.2

1444

SPAT1088

SPAT

Blood transfusion

6.2

7.2

OAB44, ,

SPAT

0.5

7.2

1037

AXX01, ,

SPAT

0.3

7.2

638

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.5

7.2

180

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

7.2

109

628

QX9VV, ,

NOMESCO Finland

30.1

7.1

JK3AT

NOMESCO Finland

Catherisation of bile duct with ultrasound guidance

30.1

7.1

JLD12

NOMESCO Finland

Endoscopic drainage of pancreatic pseudocyst

30.1

7.1

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

30.1

7.1

JFC00

NOMESCO Finland

Entero-enterostomy

20.1

7.1

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.4

7.1

824

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

7.1

384

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

7.1

132

805

A10BD07

ATC

metformin and sitagliptin; systemic

1.8

7.1

549

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

8.8

7.0

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.2

7.0

R94.5

ICD-10 Finland

Abnormal results of liver function studies

3.4

7.0

K29.6

ICD-10 Finland

Other gastritis

3.0

7.0

102

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.9

7.0

113

XX9XW, ,

NOMESCO Finland

7.5

6.9

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

13.8

6.9

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.0

6.8

A41.4

ICD-10 Finland

Sepsis due to anaerobes

6.7

6.8

Z01.2

ICD-10 Finland

Dental examination

0.8

6.8

464

5775

K03.64

ICD-10 Finland

Dental calculus supragingival

0.7

6.8

245

3374

N40

ICD-10 Finland

Hyperplasia of prostate

0.7

6.8

429

5397

WPA42

NOMESCO Finland

Family-centered psychosocial intervention in palliative care

40.2

6.8

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

40.2

6.8

K83.3

ICD-10 Finland

Fistula of bile duct

40.2

6.8

L02BG03

ATC

anastrozole; oral

40.2

6.8

I86.4

ICD-10 Finland

Gastric varices

16.7

6.7

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

6.7

492

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.2

6.7

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.7

6.7

113

671

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

3.3

6.7

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

6.7

421

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

6.7

515

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

6.7

310

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.7

6.7

127

K76.6

ICD-10 Finland

Portal hypertension

22.6

6.7

A06AH05

ATC

naldemedine; oral

22.6

6.7

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

22.6

6.7

H01CB02

ATC

octreotide; parenteral

22.6

6.7

D02

ICPC

Abdominal pain epigastric

1.8

6.7

560

NF1AA, ,

SPAT

0.2

6.6

351

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

0.4

6.6

699

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

7.8

6.6

K31.5

ICD-10 Finland

Obstruction of duodenum

12.3

6.6

D82

ICPC

Teeth/gum disease

0.7

6.6

333

4335

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.5

6.6

WZA10

NOMESCO Finland

Extensive medical or dental certificate

3.4

6.6

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.5

6.5

985

V03AE01

ATC

polystyrene sulfonate; oral

2.7

6.5

129

N05BA04

ATC

oxazepam; oral

1.3

6.5

476

3796

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

6.5

138

873

XW2AT

NOMESCO Finland

Cytology of deep organ with ultrasound quidance

70.0

6.4

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

70.0

6.4

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

70.0

6.4

6603

FHL

Delete a block

70.0

6.4

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

6.4

847

7280

G04CB02

ATC

dutasteride; oral

0.6

6.4

1629

DAX08

NOMESCO Finland

Fitting of hearing aid

0.5

6.4

1005

L13

ICPC

Hip symptom/complaint

0.7

6.4

197

2798

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

7.4

6.4

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

3.7

6.4

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

4.1

6.4

G04CA52

ATC

tamsulosin and dutasteride; systemic

0.7

6.3

159

2353

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

0.2

6.3

473

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.7

6.3

109

652

G20

ICD-10 Finland

Parkinson disease

0.3

6.3

564

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

9.3

6.3

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.3

6.3

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.0

6.3

SPAT1290

SPAT

Preparation of deceased person

18.1

6.3

D75

ICPC

Malignant neoplasm colon/rectum

18.1

6.3

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

18.1

6.3

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

6.3

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

6.3

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

6.3

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

6.3

9120/3-C22.0

ICD-O-3

Hemangiosarcoma of liver

+∞

6.3

8010/3-C24.9

ICD-O-3

Carcinoma, NOS, of billiary tract, NOS

+∞

6.3

JJA40

NOMESCO Finland

Excision of lesion of liver

+∞

6.3

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

6.3

8180/3-C22.0

ICD-O-3

Combined hepatocellular carcinoma and cholangiocarcinoma of liver

+∞

6.3

3063, ,

Kela drug reimbursment

+∞

6.3

8010/3-C22.1

ICD-O-3

Carcinoma, NOS, of intrahepatic bile duct

+∞

6.3

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

+∞

6.3

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

6.3

K62.7

ICD-10 Finland

Radiation proctitis

+∞

6.3

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

6.3

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

6.3

C25.3

ICD-10 Finland

Malignant neoplasm: Pancreatic duct

+∞

6.3

8010/3-C80.9

ICD-O-3

Carcinoma, NOS, of unknown primary site

+∞

6.3

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

6.3

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

6.3

WGA10

NOMESCO Finland

Measurement of pain intensity

+∞

6.3

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

6.3

8163/3-C24.1

ICD-O-3

Pancreatobiliary type carcinoma of ampulla of Vater

+∞

6.3

D63.0

ICD-10 Finland

Anaemia in neoplastic disease

+∞

6.3

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

6.3

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

6.3

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

6.3

C26.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of digestive system

+∞

6.3

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

6.3

C76.8

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites

+∞

6.3

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

6.3

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

6.3

L01EN02

ATC

pemigatinib; oral

+∞

6.3

L02BB04

ATC

enzalutamide; oral

+∞

6.3

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

6.3

TQW40, ,

SPAT

0.5

6.2

1061

JCA20

NOMESCO Finland

Ligature of oesophageal varices

26.7

6.2

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

26.7

6.2

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

26.7

6.2

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.6

6.2

127

795

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

3.7

6.2

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.9

6.2

411

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

4.0

6.2

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.7

6.2

121

I50.0

ICD-10 Finland

Congestive heart failure

0.6

6.1

116

1829

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

0.5

6.1

1221

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.7

6.1

103

613

ND2AA, ,

SPAT

0.2

6.1

295

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

12.5

6.1

S77

ICPC

Malignant neoplasm of skin

12.5

6.1

ZYC01, ,

SPAT

0.5

6.1

1206

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

10.0

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007566) Smooth muscle Ab [Titer] in Serum

377

414

10.76

320.11

1.5

1.2

110.34

108.53

titre

0.01

(4035726) Immunohistochemistry procedure

527

421

16.08

307.65

1.6

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

220

32.87

307.65

1.5

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1291

970

30.23

307.65

5.5

1.4

27.44

2.73

ug/l

3.42

1167

731

(40768441) Liver Pathology biopsy report

443

110.31

307.65

1.7

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

467

425

13.63

307.65

4.7

2.2

43.11

35.69

umol/l

2.15

442

376

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

851

366

36.98

307.65

5.3

1.9

1722.41

362.97

u/ml

1.12

787

290

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

572

200

38.12

307.65

5.2

1.8

902.66

32.56

u/ml

3.07

542

185

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

894

1449

9.63

307.65

5.5

2.0

0.17

0.19

g/l

15.54

847

1312

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

878

1784

7.47

307.65

10.4

2.2

29.98

8.00

umol/l

20.54

832

1565

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

145

73.78

268.51

3.9

2.3

2320.14

5.90

ug/l

1.74

145

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

254

209

13.59

260.14

1.3

1.1

1.67

1.54

g/l

2.98

243

184

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

554

1314

5.28

225.72

1.6

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

523

1225

5.27

215.54

1.6

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

646

1858

4.49

205.62

10.8

6.4

8.76

11.63

mmol/l

15.75

626

1754

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1231

5574

3.70

201.61

6.6

2.4

73.36

61.20

u/l

0.71

1198

5118

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1611

8689

4.08

201.40

27.3

3.9

28.79

12.60

umol/l

30.01

1587

8166

(3024561) Albumin [Mass/volume] in Serum or Plasma

1510

7935

3.80

193.18

15.5

4.0

31.01

35.09

g/l

115.16

1460

7296

(3033658) Prothrombin time (PT) actual/Normal

994

4113

3.56

183.53

14.2

3.8

75.62

82.33

14.05

977

4016

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1149

5236

3.46

181.05

11.4

2.6

68.82

38.51

u/l

8.04

1117

4901

(3023487) Leukocytes [#/volume] in Peritoneal fluid

121

26.60

174.59

2.2

908.52

495.58

e6/l

0.93

(3012095) Magnesium [Moles/volume] in Serum or Plasma

773

2827

3.65

171.09

5.8

2.6

0.76

0.82

mmol/l

33.68

745

2597

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

500

1482

4.06

148.56

6.3

2.3

42.09

38.89

u/l

0.27

453

1209

(3023368) Bacteria identified in Blood by Culture

1124

5510

3.10

148.52

7.1

4.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

153

137

11.92

147.38

1.6

1.1

—

(3033799) Differential panel - Peritoneal fluid

100

26.13

143.62

2.1

1.5

—

(3032080) INR in Blood by Coagulation assay

1551

9295

3.20

139.86

21.9

20.4

1.28

1.39

inr

15.69

1356

7850

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

25.96

139.02

2.1

2.0

1696.31

54119.41

e6/l

0.56

(3044007) Cell count panel - Peritoneal fluid

24.16

132.55

2.1

2.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

346

853

4.62

130.34

1.7

1.4

1.36

1.15

g/l

1.47

312

782

(3002256) Pathology report gross observation

420

1200

4.08

130.17

1.5

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

1028

5102

2.88

127.82

4.2

2.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

21.77

120.49

4.3

2.2

0.58

0.60

mmol/l

0.96

(3024471) HLA-A [Type]

27.07

117.99

1.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

375

1057

4.06

117.77

2.3

2.2

12.71

10.92

g/l

7.94

341

974

(3042733) HLA Ab [Presence] in Serum

22.04

117.11

1.4

4.7

—

(3024932) HLA-DR beta [Type]

26.73

116.01

1.0

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

168

233

7.72

115.85

8.5

5.4

885.37

595.93

iu/ml

0.38

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

822

3898

2.76

107.57

4.2

2.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1255

7366

2.61

105.57

4.9

2.5

—

estimate

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

289

745

4.31

101.78

1.3

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

105

11.67

100.81

2.3

2.2

33.95

48.85

iu/ml

0.34

(3042936) Bacteria identified in Isolate by Culture

609

2542

2.92

100.65

2.6

2.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

201

387

5.61

100.41

4.7

2.3

2.97

3.50

g/l

3.81

195

368

(3026250) Tacrolimus [Mass/volume] in Blood

17.70

100.08

43.1

38.4

6.72

7.27

ug/l

1.18

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

501

1906

3.10

97.45

3.9

2.2

260.86

233.12

u/l

1.70

486

1763

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

116

126

9.66

97.28

1.3

154.21

140.00

titre

0.06

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

641

2805

2.80

96.40

2.8

22.90

22.26

0.44

626

2570

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

190

364

5.61

95.35

1.2

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

429

1517

3.26

94.24

2.3

1.7

1.64

1.60

0.50

378

1289

(3026692) Albumin [Mass/volume] in Peritoneal fluid

16.80

92.84

1.6

1.4

10.44

14.10

g/l

1.51

(3013650) Neutrophils [#/volume] in Blood by Automated count

1403

9012

2.50

92.43

20.2

6.2

4.47

4.48

e9/l

0.01

1273

7626

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

141

214

6.97

89.36

1.3

1.4

153.56

156.27

au/ml

0.07

(3006922) Hepatitis E virus Ab [Presence] in Serum

10.20

85.05

1.2

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

148

250

6.27

84.54

1.4

—

18.26

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

148

251

6.24

84.20

1.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

650

3046

2.60

83.64

2.7

2.25

g/l

0.10

617

2776

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

138

220

6.62

83.43

1.3

1.2

342.02

278.09

u/ml

1.06

125

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

10.50

82.46

1.2

1.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

208

489

4.59

81.99

1.5

169.37

286.28

ug/g

11.48

129

313

(3022948) Iron [Moles/volume] in Serum or Plasma

676

3261

2.54

81.56

2.8

2.7

12.35

12.48

umol/l

0.17

652

2996

(3018677) aPTT in Platelet poor plasma by Coagulation assay

633

3002

2.55

78.78

3.2

1.9

31.57

29.88

6.99

622

2919

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

189

448

4.52

73.57

7.3

3.1

1.65

1.80

mg/l

1.38

173

381

(3048929) Epstein Barr virus Ab [Presence] in Serum

151

300

5.33

72.51

1.4

1.2

—

(4281824) Cell count and differential, peritoneal fluid

10.89

71.00

1.3

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

316

1104

3.17

69.59

12.4

9.6

15.48

15.97

2.04

305

1071

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

112

175

6.69

68.92

3.0

2.7

164.50

245.25

u/ml

—

(40768804) Tissue Pathology biopsy report

847

4816

2.22

67.70

2.7

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

532

2487

2.50

66.91

7.4

5.4

1.05

1.04

mmol/l

0.46

502

2267

(3016650) Hepatitis A virus Ab [Presence] in Serum

118

202

6.11

66.36

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

136

269

5.32

65.57

1.1

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

188

487

4.12

65.01

1.8

1.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

222

648

3.69

64.83

3.6

2.8

0.29

0.34

iu/ml

1.80

110

381

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1427

10070

2.16

63.86

11.3

3.2

229.52

51.61

u/l

85.19

1366

9212

(3010375) cycloSPORINE [Mass/volume] in Blood

12.73

63.39

33.8

28.2

140.10

130.48

ug/l

0.32

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

117

217

5.63

60.49

1.1

1.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

333

1300

2.84

59.70

1.8

1.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

442

1991

2.52

59.50

11.3

7.4

115.58

122.10

g/l

8.99

430

1951

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

313

1187

2.90

59.19

12.2

8.2

24.00

24.77

mmol/l

2.97

308

1177

(3019977) pH of Arterial blood

504

2422

2.40

58.82

10.5

6.9

7.41

7.42

0.21

240

1407

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

248

829

3.24

58.40

2.1

1.7

2.58

1.74

ug/l

0.53

233

713

(3016502) Oxygen saturation in Arterial blood

468

2188

2.44

57.99

10.7

7.0

96.78

94.77

14.18

453

2108

(3027801) Oxygen [Partial pressure] in Arterial blood

504

2440

2.38

57.72

10.5

6.9

13.04

11.31

kpa

12.54

482

2335

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1324

9289

2.05

57.43

10.9

6.2

1.19

1.21

mmol/l

11.85

1153

7951

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1220

8313

2.03

57.43

10.4

5.9

1.19

1.21

mmol/l

11.86

1179

7516

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

503

2440

2.37

57.30

10.5

6.9

4.97

5.04

kpa

1.09

482

2337

(3018418) pH of Serum or Plasma

883

5373

2.07

56.80

5.6

3.4

7.41

7.40

4.76

677

3897

(3014007) Fractional oxyhemoglobin in Arterial blood

327

1302

2.77

56.29

12.3

9.0

95.02

93.41

6.97

327

1295

(3021162) Amylase [Enzymatic activity/volume] in Specimen

104.51

56.09

4.0

4.8

446.62

779.33

u/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

16.53

55.65

1.1

—

(3003396) Base excess in Arterial blood by calculation

496

2424

2.35

55.34

10.4

6.8

0.36

1.07

mmol/l

3.65

411

1966

(3014111) Lactate [Moles/volume] in Serum or Plasma

405

1810

2.51

55.10

10.6

6.9

1.72

1.43

mmol/l

2.95

394

1768

(3000991) Gas panel - Venous blood

391

1724

2.54

54.71

12.6

8.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

135

314

4.51

53.60

2.0

1.5

147.89

26.34

u/ml

2.62

129

298

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

13.02

52.96

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

7.97

52.46

1.3

90.25

83.33

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

916

5785

1.99

51.89

7.4

2.2

2.33

2.35

mmol/l

3.06

877

5050

(3013826) Glucose [Moles/volume] in Serum or Plasma

1462

10840

2.01

51.72

11.8

4.8

7.43

6.94

mmol/l

11.81

1424

10320

(44816559) Phosphatidylethanol [Mass/volume] in Blood

196

624

3.35

49.77

2.8

1.4

0.20

0.33

mg/l

3.62

276

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

117

266

4.59

47.76

6.6

6.0

11.70

12.41

mg/l

0.69

108

246

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

639

3641

2.06

47.52

7.4

2.2

2.51

2.45

mmol/l

23.16

608

3202

(3024980) IgG subclass 4 [Mass/volume] in Serum

111

243

4.75

47.45

2.1

1.7

0.81

1.00

g/l

0.71

195

(42870588) Differential panel, method unspecified - Blood

871

5583

1.92

45.74

7.3

5.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

613

3484

2.05

45.61

2.2

1.9

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

305

1322

2.51

43.65

12.8

8.7

1.30

1.32

0.16

305

1312

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1636

12997

1.97

42.69

29.8

5.7

183.76

78.10

u/l

102.13

1605

12090

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

390

7012

0.46

41.79

2.4

1.9

1.52

1.30

mmol/l

4.69

345

5780

(40768795) Lymph node Pathology biopsy report

13.92

39.97

1.3

1.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

127

5.82

39.19

1.1

1.0

287.59

282.12

mg/l

0.19

115

(3036489) Thrombin time

165

551

3.15

38.57

3.7

1.8

22.89

20.86

7.18

159

490

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

85.65

37.90

2.1

1.0

46.85

19.68

u/ml

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

270

1178

2.47

37.86

13.7

8.9

23.67

24.21

mmol/l

2.05

264

1141

(3003694) ABO and Rh group [Type] in Blood

661

4074

1.88

37.60

1.5

1.3

—

(3030467) Casts [#/volume] in Urine by Automated count

784

5126

1.82

36.71

4.1

3.2

0.94

0.46

e6/l

3.24

615

3805

(3002032) Base excess in Venous blood by calculation

411

2166

2.10

36.58

5.1

3.4

1.17

1.83

mmol/l

2.78

331

1862

(3012544) pH of Venous blood

422

2248

2.08

36.49

5.1

3.5

7.37

7.38

0.40

283

1318

(3021447) Carbon dioxide [Partial pressure] in Venous blood

417

2221

2.08

36.04

5.1

3.4

5.54

5.85

kpa

7.56

410

2152

(3002030) Lymphocytes/Leukocytes in Blood

1084

7819

1.75

36.01

7.9

5.7

22.16

25.92

22.53

1045

7300

(3019069) Monocytes/Leukocytes in Blood

1072

7718

1.75

35.76

8.1

5.7

9.46

9.18

1.75

1021

7102

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

446

2452

2.02

35.27

2.1

1.9

—

(3006504) Eosinophils/Leukocytes in Blood

1062

7702

1.72

33.88

8.0

5.6

2.46

3.00

12.52

1013

7088

(3018010) Neutrophils/Leukocytes in Blood

1059

7681

1.72

33.72

7.8

5.6

61.87

58.76

12.32

1022

7248

(46235355) HIV 1 and 2 tests - Meaningful Use set

320

1583

2.19

33.31

1.4

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

463

2629

1.96

33.18

2.2

1.8

—

(3022096) Basophils/Leukocytes in Blood

1060

7713

1.71

33.17

8.1

5.7

0.55

0.65

8.55

1008

7096

(40768797) Stomach Pathology biopsy report

423

2343

1.99

32.50

1.4

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

8.10

32.03

1.8

1.4

2365288.57

1930639.80

iu/ml

—

(3026782) Osmolality of Urine

577

3565

1.83

31.68

3.7

2.9

537.54

538.99

mosm/kgh2o

0.06

530

3083

(3037522) Nuclear Ab [Titer] in Serum

386

2106

2.01

30.82

1.5

1.3

338.53

534.88

titre

3.06

500

(3019198) Lymphocytes [#/volume] in Blood

1138

8584

1.67

29.97

7.9

5.5

1.52

1.80

e9/l

15.30

1010

7367

(3002582) Erythrocytes [#/volume] in Urine

861

6041

1.69

29.93

4.2

3.3

57.58

79.02

e6/l

0.62

692

4646

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

483

2879

1.86

29.48

3.3

3.1

2.07

1.97

e6/l

0.09

269

1444

(3006315) Basophils [#/volume] in Blood

1118

8462

1.64

28.51

7.8

5.4

0.04

e9/l

4.37

970

7106

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

350

1893

2.01

28.48

4.6

3.4

—

(3001604) Monocytes [#/volume] in Blood

1113

8420

1.64

28.39

7.9

5.4

0.64

0.63

e9/l

0.85

970

7065

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

6.21

27.57

1.5

1.3

—

(3013115) Eosinophils [#/volume] in Blood

1136

8717

1.62

26.75

8.2

5.5

0.17

0.21

e9/l

15.88

991

7426

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

227

1069

2.25

26.41

1.6

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

117

4.97

26.30

1.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

450

2753

1.79

24.77

1.7

1.3

3.72

2.80

g/l

9.91

347

1554

(3004809) Band form neutrophils/Leukocytes in Blood

202

3.81

24.45

3.3

2.5

1.85

1.42

0.39

165

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

268

1398

2.04

23.90

5.1

3.1

1.21

1.22

mmol/l

2.73

249

1171

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1387

16151

0.63

23.62

5.5

5.6

4.23

4.37

mmol/l

5.04

1236

14855

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1372

16014

0.63

23.59

5.4

5.5

1.29

1.40

mmol/l

20.17

1211

14608

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

498

3190

1.72

23.17

3.3

3.0

1.13

1.32

e6/l

0.45

286

1764

(3018095) Leukocytes [#/volume] in Urine

897

6675

1.58

22.84

4.9

3.9

66.29

124.14

e6/l

2.84

710

4779

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

722

5116

1.61

22.59

3.0

2.4

3.57

2.83

mg/l

7.97

640

4346

(3031040) Bacteria [#/volume] in Urine by Automated count

1386

11397

1.57

22.51

5.6

4.8

1362.17

2696.55

e6/l

0.63

210

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1440

16534

0.64

21.58

5.9

6.5

2.42

2.50

mmol/l

2.67

1277

15166

(3012501) Base excess in Blood by calculation

106

383

2.86

21.52

4.9

4.7

2.26

2.75

mmol/l

1.12

253

(3008152) Bicarbonate [Moles/volume] in Arterial blood

258

1387

1.97

21.03

7.5

6.1

23.49

24.43

mmol/l

3.16

243

1335

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

256

3.25

20.73

1.2

1.3

—

(3017181) Myelocytes/Leukocytes in Blood

254

1385

1.94

19.83

4.9

3.8

1.11

0.78

1.14

147

313

(3007930) Methemoglobin/Hemoglobin.total in Blood

184

900

2.14

19.37

6.8

4.3

0.85

0.00

171

857

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1421

16252

0.65

19.31

5.7

5.8

6.51

6.14

mmol/l

15.71

1266

14675

(3000850) Epithelial cells [#/volume] in Urine

603

4240

1.58

18.85

3.6

2.6

6.64

4.58

e6/l

3.28

567

3832

(40758558) Short blood count panel - Blood

675

4895

1.54

18.30

13.4

4.7

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

21.90

18.17

1.2

1.4

1.70

0.71

ml/s/173m2

—

(3019060) Gas panel - Arterial blood

241

1329

1.91

18.14

5.7

4.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1336

15392

0.67

17.82

4.9

4.7

1.38

1.28

mmol/l

4.68

1179

13888

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

18.20

17.78

1.4

1.1

—

(3047181) Lactate [Moles/volume] in Blood

135

603

2.32

17.72

7.5

5.0

1.75

1.37

mmol/l

1.38

116

538

(3045142) Bone marrow Pathology biopsy report

5.21

17.70

1.7

1.1

—

(3026008) Bacteria identified in Urine by Culture

749

5603

1.51

17.37

3.3

3.4

—

(3018572) Chloride [Moles/volume] in Blood

100

397

2.59

16.96

8.8

5.6

105.81

105.01

mmol/l

1.19

361

(3039000) Anion gap in Blood by calculation

100

397

2.59

16.96

8.8

5.6

12.17

11.55

mmol/l

0.81

361

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

251

1438

1.84

16.74

4.2

2.5

62.92

61.96

ml/min/173m2

0.12

114

594

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

16.68

1.0

0.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

188

980

2.00

16.65

6.8

4.2

1.70

1.61

0.65

177

934

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

147

3.67

16.63

1.1

1.2

54.19

51.88

u/l

0.11

127

(1761868) Lipid panel - Serum or Plasma

349

5254

0.60

16.57

4.0

3.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

4.86

16.38

2.4

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

178

3.38

16.31

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

307

1881

1.73

16.29

4.5

2.9

4.61

4.44

kpa

0.94

301

1815

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1333

15271

0.68

16.20

4.9

5.0

2.37

2.04

mu/l

5.92

1185

13818

(40760892) CBC W Ordered Manual Differential panel - Blood

476

3277

1.58

15.93

5.7

4.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1416

16013

0.68

15.72

9.3

7.5

42.73

40.76

mmol/mol

9.36

1288

14798

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

4.39

15.69

1.1

1.2

235.62

91.25

u/l

2.53

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

4.46

15.20

1.0

1.2

59.56

19.76

u/l

2.08

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

397

2.48

14.98

1.8

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

398

2.48

14.90

1.8

1.4

—

(3002179) Metamyelocytes/Leukocytes in Blood

230

1329

1.81

14.87

5.1

3.6

0.72

0.61

0.44

130

305

(1616796) Gas panel - Central venous blood

101

434

2.39

14.50

3.9

4.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

242

1447

1.75

13.91

3.0

1.9

422.29

370.25

nmol/l

3.12

226

1308

(3021440) Promyelocytes/Leukocytes in Blood

229

1349

1.78

13.86

5.3

3.9

0.09

0.07

0.28

126

278

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

5.05

13.84

2.8

1.3

26.45

28.58

umol/l

0.64

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

220

1286

1.79

13.67

1.9

1.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

144

3.38

13.43

1.9

1.5

17.28

21.37

ng/l

1.20

144

(21494434) Karyotype in Bone marrow

4.03

13.36

1.2

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

540

7134

0.68

13.29

3.9

4.0

22.35

24.59

2.48

259

3542

(3035715) Granulocytes [#/volume] in Blood

225

2.85

13.16

3.3

3.0

4.29

4.65

e9/l

0.34

225

(3035933) Granulocytes/Leukocytes in Blood

268

2.66

12.82

3.4

2.8

57.89

60.02

0.60

268

(3000494) Fungus identified in Specimen by Culture

307

2000

1.62

12.74

1.8

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

355

5062

0.64

12.65

2.7

3.0

0.74

0.75

ug/l

0.08

247

3485

(3025159) Blasts/Leukocytes in Blood

226

1368

1.73

12.41

5.5

4.0

0.04

0.01

0.66

114

255

(3028308) Erythrocytes [#/volume] in Pleural fluid

197

2.84

11.46

1.6

1.4

26022.32

59852.91

e6/l

0.51

113

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

121

619

2.01

11.32

1.3

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1076

12440

0.74

10.98

4.2

3.9

14.92

15.06

pmol/l

0.96

949

11175

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

260

2.54

10.95

1.8

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

148

3.08

10.91

2.4

2.8

—

(3022145) Colonoscopy Study observation

254

1639

1.62

10.90

1.7

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

5.16

10.79

2.4

2.6

2.23

1.38

0.50

(3023199) Leukocytes [#/volume] in Pleural fluid

227

2.64

10.75

1.7

1.5

1194.09

1364.15

e6/l

0.14

162

(3027273) Bicarbonate [Moles/volume] in Venous blood

180

1070

1.74

10.54

4.5

3.0

23.82

25.20

mmol/l

4.81

174

1027

(4062490) Immunoglobulin typing, IgG

141

3.09

10.49

1.5

1.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

14.26

10.48

1.9

1.1

—

(3012441) Differential panel - Pleural fluid

190

2.78

10.47

1.7

1.4

—

(3017354) Segmented neutrophils/Leukocytes in Blood

152

3.00

10.43

3.2

2.4

59.76

60.31

0.05

119

(3027135) IgG subclass 1 [Mass/volume] in Serum

142

3.07

10.36

1.5

1.3

7.96

7.32

g/l

0.28

111

(3024139) IgG subclass 3 [Mass/volume] in Serum

142

3.07

10.36

1.5

1.3

0.51

0.43

g/l

0.57

110

(3028192) IgG subclass 2 [Mass/volume] in Serum

142

3.07

10.36

1.5

1.3

3.36

3.10

g/l

0.25

110

(3042111) Morphology [Interpretation] in Bone marrow Narrative

180

2.82

10.35

1.4

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

253

1653

1.60

10.31

1.9

1.6

65.23

66.36

g/l

1.20

229

1473

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

3.67

10.25

1.7

1.5

4.40

7.39

u/l

0.51

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

13.17

10.15

1.2

—

(40761536) Microorganisms panel - Urine sediment

198

1223

1.68

10.08

5.3

3.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

352

2.23

9.68

1.7

1.3

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

117

3.20

9.60

1.7

1.5

—

(3027945) Reticulocytes/Erythrocytes in Blood

350

2496

1.48

9.51

2.8

2.0

2.03

1.74

4.03

313

2183

(40768806) Pleura Pathology biopsy report

178

2.73

9.43

1.8

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

726

8775

0.74

9.41

4.5

4.4

2.16

2.19

ug/l

0.08

611

7896

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

192

2.64

9.19

1.9

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

882

7374

1.32

9.12

3.8

3.1

210.32

141.94

ug/l

7.65

827

6749

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

162

977

1.71

9.02

1.8

1.6

1.48

1.54

g/l

0.36

134

838

(3003181) Sodium [Moles/volume] in Urine

368

2.13

8.70

1.3

1.4

51.96

60.85

mmol/l

1.02

289

(3007853) Bacteria identified in Skin by Aerobe culture

297

2091

1.48

8.57

1.9

1.8

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

101

536

1.93

8.56

1.5

1.4

21.04

20.16

iu/ml

—

(40768793) Breast Pathology biopsy report

4.07

8.52

1.2

—

(3021589) Normoblasts [#/volume] in Blood

864

7252

1.31

8.52

25.0

10.6

0.00

e9/l

0.76

693

5853

(3045788) Cell count panel - Pleural fluid

188

2.59

8.51

1.8

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

181

2761

0.63

8.38

1.2

1.3

57.77

37.37

iu/ml

0.52

806

(3025941) Bacteria identified in Stool by Culture

133

776

1.76

8.34

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

303

2.21

8.26

1.6

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

4.55

8.12

2.0

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

22.10

8.01

5.8

3.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

123

711

1.77

7.97

1.4

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

308

2.18

7.95

1.7

1.3

—

(3004775) Volume in Urine collected for unspecified duration

164

2.59

7.52

2.3

795.24

613.19

1.61

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

164

2.59

7.52

2.5

2.7

—

(3020891) Body temperature

164

1042

1.62

7.50

5.1

4.3

36.88

36.90

°c

0.38

164

1026

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

130

2.80

7.49

1.3

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

412

1.98

7.44

1.6

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3.45

7.39

2.2

1.5

19.92

53.33

u/l

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.76

7.35

2.3

2.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

253

2.24

7.32

1.7

1.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

116

2.87

7.22

1.6

11.59

15.43

umol/l

2.98

102

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

453

1.91

7.17

1.3

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1441

15630

0.78

7.02

42.4

16.3

76.37

73.19

ml/min/173m2

6.68

1373

14487

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

174

2574

0.65

6.95

1.2

1.3

18.41

15.60

u/ml

0.14

939

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

130

2.72

6.93

2.0

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

208

2.34

6.92

1.9

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

396

1.95

6.86

1.6

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

204

2.33

6.76

1.7

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

204

2.33

6.76

1.7

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

204

2.33

6.76

1.7

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

204

2.33

6.76

1.7

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

487

1.84

6.63

4.3

3.7

2.61

1.82

index

0.39

245

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

504

4043

1.32

6.59

4.4

4.5

390.29

450.73

ng/l

0.15

437

3523

(3023520) Reticulocytes [#/volume] in Blood

266

1929

1.43

6.54

2.9

2.0

76.43

67.02

e9/l

2.77

198

1431

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

3.66

6.47

1.3

22.07

35.54

u/l

0.98

(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid

+∞

6.25

1.0

0.0

17.67

—

umol/l

—

(3021374) Sirolimus [Mass/volume] in Blood

+∞

6.25

15.2

0.0

8.87

—

ug/l

—

(1617658) Protocol used for examination of sentinel lymph nodes

+∞

6.25

1.0

0.0

—

(4024509) Urine culture

936

0.47

6.13

2.1

2.0

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

130

823

1.62

6.08

1.4

1.6

3.74

24.23

iu/ml

—

(3010813) Leukocytes [#/volume] in Blood

1669

17685

0.78

6.02

60.5

24.8

7.37

6.88

e9/l

10.43

1623

17099

(3000963) Hemoglobin [Mass/volume] in Blood

1669

17685

0.78

6.02

61.0

25.0

121.58

135.40

g/l

187.96

1635

17385

(3026361) Erythrocytes [#/volume] in Blood

1669

17684

0.78

6.01

60.4

24.8

4.10

4.46

e12/l

115.43

1621

17094

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1669

17684

0.78

6.01

62.5

25.3

36.61

40.27

127.69

1633

17369

(3035941) MCH [Entitic mass]

1669

17684

0.78

6.01

60.2

24.7

30.25

30.53

6.35

1635

17375

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.94

6.00

1.8

1.3

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1669

17682

0.78

5.98

60.3

24.8

91.36

91.75

2.29

1637

17372

(3007461) Platelets [#/volume] in Blood

1669

17681

0.78

5.97

60.5

24.8

225.07

236.40

e9/l

6.10

1623

17172

(3000093) Morphology [Interpretation] in Blood Narrative

179

2.31

5.86

1.2

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

433

1.83

5.86

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

433

1.83

5.86

1.4

1.3

—

(3016750) Collection duration of Urine

107

2.73

5.86

2.2

1.9

504.57

494.57

min

0.26

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.96

5.84

1.8

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

107

652

1.67

5.82

2.2

2.8

—

(3051611) Lipemic interference index of Serum or Plasma

176

2.30

5.63

4.4

3.8

20.45

12.18

index

1.35

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.75

5.60

1.6

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

7.09

5.43

1.0

1.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1663

17567

0.79

5.32

53.5

22.3

84.59

85.48

umol/l

0.37

1635

17272

(21494814) CD8 cells/Lymphocytes in Specimen

5.03

5.25

1.4

3.0

45.40

24.20

2.76

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

541

1.69

5.18

2.5

2.2

160.19

93.39

ug/min

0.46

317

(3037121) Protein [Mass/volume] in Urine

101

631

1.63

5.03

3.8

2.8

755.85

409.22

mg/l

0.40

233

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

449

3665

1.28

5.02

2.6

1.6

2.97

1.37

mg/l

6.03

379

2899

(3026493) Urate [Moles/volume] in Serum or Plasma

579

4885

1.25

4.89

3.8

2.6

370.47

367.36

umol/l

0.25

512

4154

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

357

1.82

4.79

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

888

7858

1.22

4.74

4.8

4.4

36.45

110.21

ng/l

2.28

759

6174

(3009343) pH of Capillary blood

189

1376

1.41

4.57

3.9

3.8

7.42

7.41

0.20

165

1135

(3042631) Mycobacterium sp identified in Specimen

223

1.99

4.41

2.3

2.9

—

(1002224) Polysomnography panel

552

0.43

4.36

1.0

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

253

1949

1.34

4.32

3.5

3.4

211.33

259.91

ng/l

1.33

235

1806

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

101

2.49

4.30

1.8

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

117

788

1.51

4.26

2.0

1.8

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.15

4.21

1.2

19.04

6.97

ug/l

—

(21494815) CD4 cells/Lymphocytes in Specimen

2.76

4.18

2.0

2.4

34.06

42.59

1.48

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

269

0.29

4.09

1.0

1.2

1.43

1.51

g/l

—

269

(3014148) Varicella zoster virus Ab [Titer] in Serum

129

2.26

4.06

1.0

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

190

1414

1.38

4.06

4.0

3.8

4.87

5.19

kpa

7.02

178

1339

(3000012) Reticulocyte production index

295

1.82

4.05

1.9

1.6

1.04

0.88

0.70

199

(21494755) Public health laboratory ask at order entry panel

693

0.51

4.01

1.3

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

198

1490

1.36

3.95

3.2

3.9

80.97

97.34

ng/l

3.13

178

1251

(3009214) Lutropin [Units/volume] in Serum or Plasma

262

1.85

3.91

1.3

12.45

7.15

u/l

1.64

207

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

164

1209

1.38

3.73

4.0

3.7

1.70

2.04

mmol/l

0.44

109

877

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

141

2.14

3.71

1.4

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

101

682

1.50

3.67

2.6

1.5

35.64

35.17

mg/l

0.06

574

(40768800) Prostate Pathology biopsy report

122

2.23

3.67

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

101

683

1.50

3.65

2.6

1.5

49.55

49.89

mg/l

0.02

576

(3043409) Potassium [Moles/volume] in Arterial blood

618

1.53

3.65

4.2

4.0

3.96

3.94

mmol/l

0.11

611

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

7.80

3.56

1.1

4.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

607

1.52

3.52

2.5

1.5

1.74

1.63

ratio

0.12

361

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

152

2.05

3.46

1.5

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

201

1.91

3.44

1.4

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

536

4634

1.21

3.44

4.6

3.4

0.01

0.19

estimate

0.50

196

1408

(3026389) Candida sp identified in Specimen by Organism specific culture

180

1.96

3.44

1.1

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

106

735

1.46

3.41

1.8

1.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

188

1.93

3.39

1.5

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.58

3.38

1.7

1.3

56.88

108.41

umol/l

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

127

2.14

3.36

1.3

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

127

2.14

3.36

1.3

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

127

2.14

3.36

1.3

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

495

0.48

3.33

1.2

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.43

3.31

1.1

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

190

1.91

3.29

1.5

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

184

1411

1.33

3.28

1.8

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1649

17209

0.84

3.20

34.5

10.8

42.81

25.36

u/l

70.15

1621

16481

(3037756) Immunofixation for Serum or Plasma

380

1.62

3.19

1.3

1.2

—

(3019225) pH of Specimen

224

1773

1.29

3.18

4.5

3.8

7.37

7.36

0.44

203

1171

(3035880) pH of Pleural fluid

2.32

3.17

1.0

1.4

7.44

0.04

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

179

2302

0.76

3.16

4.4

5.5

32.66

33.26

0.27

123

1474

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

132

2.06

3.07

1.2

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

188

1.88

3.06

1.5

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.59

3.04

1.3

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.59

3.04

1.3

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.59

3.04

1.3

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.59

3.04

1.3

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

356

0.42

3.04

1.2

1.6

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1247

13278

0.86

3.01

52.7

21.8

331.03

332.20

g/l

4.31

1236

13181

(1761482) Bacteria [#/volume] in Urine by Culture

514

1.52

3.01

4.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

10.02

2.98

1.0

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

352

0.42

2.97

1.2

1.8

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

199

1.82

2.90

1.5

1.2

—

(40768446) Kidney Pathology biopsy report

2.60

2.87

1.1

1.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

586

1.47

2.86

1.7

1.5

0.00

g/l

-0.00

522

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

116

2.08

2.83

1.3

16.92

14.68

u/l

0.68

109

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

102

1396

0.72

2.75

1.3

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

651

1.43

2.72

1.5

1.9

44.67

38.42

u/l

1.54

539

(3023103) Potassium [Moles/volume] in Serum or Plasma

1663

17279

0.85

2.72

49.3

21.3

4.01

4.02

mmol/l

0.97

1630

16857

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

102

737

1.40

2.69

1.6

1.4

11.30

10.28

g/l

0.96

631

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

197

1.79

2.68

1.5

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

170

0.29

2.68

1.0

1.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

129

970

1.35

2.67

2.6

2.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

113

834

1.37

2.63

1.7

1.4

7.63

7.51

g/l

0.25

733

(3008295) Osmolality of Serum or Plasma

184

1.81

2.61

1.1

1.4

281.50

273.82

mosm/kgh2o

0.89

131

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.68

2.59

1.0

1.1

—

0.09

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

557

1.45

2.59

1.7

1.5

0.00

g/l

-0.00

520

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

149

1.89

2.56

1.0

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

112

831

1.37

2.54

1.7

1.4

4.14

3.75

g/l

2.00

731

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

649

0.61

2.53

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1663

17253

0.86

2.53

49.1

21.1

137.72

139.76

mmol/l

114.85

1633

16856

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

108

2.05

2.51

1.2

1.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

112

833

1.36

2.50

1.7

1.4

4.35

4.16

g/l

1.40

735

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

607

1.42

2.42

1.7

1.5

0.07

0.02

g/l

0.50

550

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.22

2.37

1.5

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.22

2.37

1.5

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

111

1.99

2.35

1.2

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

105

782

1.36

2.34

1.7

1.4

3.05

2.95

g/l

0.51

683

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.76

2.27

1.4

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.76

2.27

1.4

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.76

2.27

1.4

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

4.62

2.27

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

172

0.35

2.26

1.2

—

87.00

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

483

4284

1.16

2.23

1.8

55164201.18

39214416.97

pmol/l

0.14

397

3486

(3011648) Oxygen content in Venous blood

202

1.69

2.21

4.1

1.9

11.06

10.06

0.75

202

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

195

0.41

2.17

1.1

1.2

—

62.73

—

(3005322) IgE [Units/volume] in Serum or Plasma

941

0.70

2.16

1.3

301.24

275.50

u/ml

0.10

872

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

769

7062

1.14

2.15

3.3

3.5

1496.51

1710.12

ng/l

0.60

681

6168

(3019309) Folate [Moles/volume] in Red Blood Cells

450

3981

1.16

2.15

1.9

1.8

1191.94

1162.94

nmol/l

0.26

347

2997

(44786800) Granulocytes/Leukocytes in Body fluid

4.29

2.15

1.0

1.4

42.83

13.10

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

585

0.63

2.15

1.4

1.6

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.63

2.14

1.1

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

213

1.65

2.10

2.0

1.8

2.15

1.53

g/24h

0.46

110

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

357

1.50

2.08

1.2

1.4

0.70

0.88

nmol/l

1.08

295

(3020650) Glucose [Presence] in Urine

2.57

2.08

1.4

1.7

0.00

0.14

estimate

0.80

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.71

2.07

1.2

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

2.71

2.07

1.1

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

206

1708

1.23

2.04

2.9

2.3

238.51

179.07

ug/g

0.87

176

1364

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

194

0.41

2.04

1.3

1.9

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.41

2.02

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

231

1.61

2.02

1.9

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

2.51

2.01

1.7

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

526

0.62

2.00

1.4

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

703

0.68

1.97

1.2

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

720

1.33

1.94

1.7

1.5

0.50

0.47

g/l

0.04

610

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.76

1.93

1.0

1.1

—

(3034426) Prothrombin time (PT)

2.40

1.85

1.5

1.3

29.36

28.00

0.50

(21494890) Protein electrophoresis panel - 24 hour Urine

175

1.67

1.83

1.5

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.05

1.80

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.05

1.80

2.0

1.3

—

(3045414) Leukocytes [Presence] in Urine

143

1754

0.80

1.79

2.4

2.0

0.04

0.01

estimate

0.34

334

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

215

1.59

1.79

1.3

1.2

1.47

3.05

u/ml

0.92

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

732

1.31

1.76

4.4

4.3

24.38

24.81

mmol/l

0.71

656

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

752

6968

1.12

1.76

5.0

4.0

0.12

0.09

estimate

0.09

209

1493

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.03

1.75

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.03

1.75

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

545

5970

0.88

1.73

1.8

1.7

18.59

19.62

nmol/l

0.99

496

4986

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.67

1.72

1.1

1.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

2.14

1.71

2.8

3.5

18.19

29.90

mu/l

0.70

(3000475) Leukocytes [#/volume] in Synovial fluid

529

0.66

1.71

1.5

16557.40

14949.95

e6/l

0.07

382

(3022313) Gas panel - Capillary blood

120

963

1.26

1.64

4.3

4.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.07

1.59

1.0

1599.54

1537.76

miu/ml

0.07

(4268621) Lupus anticoagulant assay

153

1.64

1.53

2.4

2.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1074

0.77

1.53

1.2

1.3

—

(3008898) HLA-B27 [Presence]

357

0.61

1.50

1.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.86

1.50

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

230

0.52

1.48

1.1

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.44

1.48

1.2

1.1

81.89

96.72

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

254

1.46

1.40

2.1

2.2

27.67

18.30

mg/l

0.46

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

591

6375

0.90

1.40

2.1

2.3

172.19

241.82

u/l

2.30

558

5976

(3035350) Ketones [Presence] in Urine by Test strip

982

9318

1.10

1.37

4.8

4.0

10.87

3.17

estimate

0.50

250

1891

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

237

2072

1.16

1.36

2.4

2.5

5.38

7.49

ug/l

1.67

210

1800

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.95

1.36

1.0

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

248

1.46

1.35

1.1

314.84

91.34

iu/ml

—

(3040151) Glucose [Moles/volume] in Capillary blood

273

1.44

1.35

6.7

8.4

8.82

7.55

mmol/l

0.98

231

(3044242) Glucose [Moles/volume] in Arterial blood

143

1.61

1.35

2.0

1.7

8.10

8.15

mmol/l

0.03

143

(3004451) EKG impression Narrative

128

1.65

1.33

1.1

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

968

9190

1.09

1.33

4.7

3.9

0.00

estimate

0.50

240

1842

(3049717) Cytology report of Urine Cyto stain

657

1.27

1.32

2.6

1.8

—

(3015736) pH of Urine

787

7406

1.10

1.30

4.3

3.5

6.24

6.27

0.39

436

4021

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

2.50

1.30

2.8

1.2

103.50

110.00

—

(3029937) Albumin [Presence] in Urine by Test strip

576

5339

1.11

1.30

5.2

4.0

0.00

estimate

0.50

196

1635

(3019832) Treponema pallidum Ab [Presence] in Serum

530

0.71

1.28

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.40

1.24

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

119

0.42

1.24

2.4

1.9

88.18

124.30

ng/l

—

119

(3000330) Specific gravity of Urine by Test strip

123

1027

1.21

1.23

4.1

3.5

1.02

ratio

1.74

116

940

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

212

1.47

1.23

1.3

1.2

2.30

8.01

u/ml

1.96

102

(3018333) Ribosomal P Ab [Presence] in Serum

109

1.66

1.18

1.1

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

447

1.31

1.16

1.2

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

982

9371

1.09

1.15

4.8

4.0

4.43

0.02

estimate

0.50

229

1728

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.81

1.15

1.1

—

(3017569) Oxygen content in Arterial blood

142

1.55

1.14

2.0

1.8

14.43

16.54

3.29

142

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

762

8049

0.92

1.13

2.8

2.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

112

0.45

1.13

1.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

2.38

1.09

1.0

1.2

50.60

62.71

ug/l

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.95

1.08

1.3

1.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

444

1.29

1.07

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

113

1.60

1.05

1.1

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

360

0.69

1.05

1.2

1.3

14.28

745.53

e6/l

1.39

299

(3014051) Protein [Presence] in Urine by Test strip

495

4605

1.10

1.04

3.3

3.1

0.00

0.06

1.31

161

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1165

0.83

1.00

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

449

1.28

1.00

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

115

1.57

0.99

1.1

1.2

—

(40765096) Chromosome analysis panel by Banding

2.18

0.98

1.4

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

354

0.70

0.97

1.2

1.3

2.12

32.18

e6/l

1.10

277

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.00

0.95

0.0

2.4

—

43.80

—

(3003129) Base excess in Capillary blood by calculation

257

0.66

0.93

3.0

2.1

-0.53

0.07

mmol/l

0.19

247

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

182

0.60

0.89

1.3

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.07

0.89

1.0

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

127

1.50

0.88

1.1

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

377

1.28

0.88

1.4

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

119

1.52

0.88

1.1

1.2

—

(3011288) Drugs identified in Urine by Screen method Nominal

130

0.54

0.87

4.3

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.58

0.87

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.58

0.87

1.2

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

531

1.23

0.86

2.7

2.2

118.73

132.07

g/l

4.52

427

(3005570) Glucose [Moles/volume] in Urine

204

0.64

0.86

1.7

2.0

—

(4034850) Laboratory test

636

0.80

0.85

19.8

11.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

680

0.80

0.85

1.3

1.7

5.58

6.31

iu/ml

0.13

157

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

120

1.50

0.85

1.1

1.2

—

(3014271) Vancomycin [Susceptibility]

120

1.50

0.85

2.4

3.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

120

1.50

0.85

1.1

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

191

0.63

0.84

1.3

1.0

—

(3028300) Cannabinoids [Presence] in Urine

203

0.64

0.84

1.9

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

196

1.38

0.84

1.3

1.4

—

nmol/l

—

(3027008) Opiates [Presence] in Urine

202

0.64

0.82

1.9

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

355

1.27

0.81

1.2

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

138

1.45

0.81

1.1

1.2

—

(3027944) Amphetamines [Presence] in Urine

201

0.64

0.81

1.9

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

200

0.65

0.79

1.9

1.4

—

(3028433) Virus identified in Specimen by Culture

1.67

0.78

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.67

0.78

1.4

17.69

9.66

ug/l

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

122

1391

0.87

0.78

2.2

12.66

15.26

nmol/l

2.18

103

1239

(3009015) Lactate [Moles/volume] in Synovial fluid

0.00

0.78

0.0

1.2

—

8.96

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

182

1.38

0.78

1.4

1.3

27.68

27.58

iu/l

0.00

146

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

219

2405

0.90

0.77

14.1

7.7

—

(3044941) Cell count panel - Synovial fluid

371

0.75

0.76

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.70

0.75

1.3

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.70

0.75

9.8

7.2

5.90

5.30

kpa

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

193

1.35

0.73

1.2

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

756

1.17

0.72

3.3

3.1

4.20

4.43

pmol/l

1.49

657

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

241

0.70

0.71

1.2

1.4

—

(3014891) Appearance of Pleural fluid

1.93

0.70

2.4

1.4

—

(3006270) Folate [Moles/volume] in Blood

178

1.35

0.68

1.2

353.12

355.12

nmol/l

0.01

142

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

307

0.75

0.68

1.3

1.2

—

62.03

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

226

0.71

0.66

1.3

1.4

56.80

63.16

—

148

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

0.53

0.66

9.2

4.4

14.90

13.29

—

(3016879) Cocaine [Presence] in Urine

190

0.68

0.65

1.9

1.4

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

1.52

0.62

1.0

1.1

—

4.80

—

(3020682) Albumin/Creatinine [Ratio] in Urine

752

7241

1.06

0.62

4.7

4.2

12.16

8.04

mg/mmol

1.55

501

4638

(3004716) Salmonella sp identified in Stool by Organism specific culture

581

1.18

0.62

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

102

0.59

0.62

1.0

1.1

—

0.52

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

357

0.78

0.61

1.4

1.9

2.12

20.20

iu/l

—

141

(40757373) Influenza virus identified in Isolate

1.57

0.60

1.0

1.5

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

0.00

0.60

0.0

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

562

0.83

0.58

1.3

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

231

0.73

0.58

1.1

1.2

—

4.50

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.46

0.58

1.6

1.9

548.80

270.02

mu/l

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

176

1.31

0.56

1.0

1.3

—

84.75

—

(3000492) Spirometry study

130

1437

0.90

0.56

1.4

1.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.62

0.55

1.0

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.62

0.55

1.0

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

515

0.83

0.55

1.7

1.9

58.32

43.83

nmol/l

2.23

491

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

124

0.64

0.54

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

181

1668

1.09

0.53

1.3

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.43

0.52

1.1

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

132

0.68

0.52

1.2

112.89

102.41

pmol/l

—

132

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.46

0.50

8.0

7.0

10.18

10.31

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

572

0.85

0.49

2.9

3.3

0.82

0.83

nmol/l

0.09

462

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

154

1.30

0.48

1.2

93.65

94.14

0.03

145

(3020874) Milk IgE Ab [Units/volume] in Serum

1.52

0.48

1.0

—

2.20

u/ml

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1655

16337

1.05

0.46

43.1

16.6

38.13

26.71

mg/l

31.94

1614

13511

(4195642) Thrombophilia screening test

191

1.26

0.46

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

117

0.68

0.45

1.8

1.5

148.99

160.72

pmol/l

—

117

(3044927) Protein electrophoresis panel - Urine

254

0.79

0.45

1.4

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.59

0.45

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

174

1.27

0.45

1.6

2.1

1.53

1.31

u/field

0.23

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

441

1.16

0.44

1.5

1.6

0.24

0.23

g/l

0.37

420

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

872

8946

0.96

0.44

2.2

2.3

87.97

93.60

pmol/l

3.14

478

4788

(3035320) C reactive protein [Mass/volume] in Body fluid

130

0.69

0.43

2.7

2.8

37.22

31.26

mg/l

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.38

0.42

1.7

1.3

—

(3022621) pH of Urine by Test strip

133

1441

0.92

0.42

3.3

2.9

5.99

6.06

0.52

112

1026

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.4

—

51.56

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.40

0.0

1.2

—

330.12

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

571

0.87

0.40

1.6

1.5

39.47

22.24

u/ml

—

101

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.40

0.0

1.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.40

0.0

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.40

0.0

1.0

—

57.77

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

160

0.75

0.39

1.2

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.39

0.0

1.6

—

(3017732) Neutrophils [#/volume] in Blood

211

1989

1.07

0.38

4.9

2.9

5.78

4.77

e9/l

0.40

188

1639

(3023511) Choriogonadotropin [Units/volume] in Urine

1.39

0.38

1.0

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.32

0.37

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.32

0.37

1.3

133.67

169.54

mmol/24h

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.33

0.37

1.0

—

(3023419) Bacteria identified in Sputum by Culture

281

1.18

0.36

1.7

2.5

—

(3025130) Human papilloma virus identified in Specimen

0.65

0.35

2.2

1.8

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.63

0.35

1.0

1.1

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

167

0.78

0.34

1.4

7.95

26.04

—

112

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.67

0.32

1.5

2.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

187

0.80

0.32

1.0

1.1

0.36

1.66

u/ml

—

103

(1001926) Buprenorphine [Presence] in Urine by Screen method

154

0.78

0.32

1.9

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

433

0.88

0.31

2.5

3.6

33.69

29.71

mg/l

0.33

312

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.27

0.30

1.3

—

(3024263) Appearance of Synovial fluid

110

0.73

0.28

1.1

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

478

1.11

0.28

1.4

1.5

1.43

6.65

iu/ml

0.38

(36660697) Celiac disease serology panel - Serum

110

1175

0.93

0.28

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.25

0.27

2.4

2.6

10.40

9.76

kpa

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.25

0.27

2.4

2.6

4.43

5.01

kpa

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.25

0.27

1.1

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

224

1.16

0.27

1.3

1.4

1.22

8.58

nmol/l

0.45

215

(4146454) Self-monitoring of blood glucose

262

1.15

0.26

3.0

2.8

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

192

0.83

0.25

1.4

1.2

11597.50

148080.93

e6/l

—

134

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.18

0.24

1.0

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

169

0.83

0.24

1.0

1.4

—

75.71

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.32

0.23

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.28

0.23

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

0.74

0.22

1.7

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.22

0.22

1.0

1.1

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1256

12689

0.98

0.21

5.3

4.4

23.20

13.02

mm/h

45.06

1155

11751

(3002619) Bacteria identified in Specimen by Culture

1.19

0.21

1.0

1.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.6

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.8

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

10.02

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.16

0.21

1.0

1.2

18.80

10.02

mm/h

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.8

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

72.75

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3019174) dRVVT (LA screen)

0.00

0.20

0.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.20

0.0

1.5

—

(3019150) Specific gravity of Urine by Refractometry

428

4378

0.97

0.20

5.3

4.2

1.02

kg/l

0.41

309

2861

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

122

0.82

0.19

1.5

1.2

2.03

2.26

mmol/l

—

112

(3016018) Differential panel - Cerebral spinal fluid

154

0.84

0.19

1.0

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

175

0.86

0.18

1.0

1.4

—

250.87

—

(3009508) Creatinine [Moles/volume] in Urine

729

7185

1.02

0.17

3.8

3.5

7.16

7.45

mmol/l

1.24

599

6003

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

337

3294

1.03

0.16

1.3

1.38

1.67

u/ml

0.41

852

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

187

1.12

0.15

1.2

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

0.77

0.15

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.75

0.15

1.5

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

768

0.95

0.14

1.2

155.27

109.76

u/ml

0.23

284

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

179

1.12

0.14

1.0

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

392

1.07

0.14

1.8

2.0

14.46

12.41

mg/l

0.58

360

(3045424) Erythrocytes [Presence] in Urine

866

0.96

0.13

2.4

2.0

0.00

1.00

estimate

0.50

250

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

104

1.15

0.12

4.3

4.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

137

0.88

0.12

1.0

1.1

4.14

1.89

u/ml

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1310

13023

1.01

0.11

53.4

20.1

15.16

13.74

131.94

1299

12775

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.14

0.10

1.2

1.8

42.00

70.64

nmol/24h

—

(3012516) Albumin [Mass/volume] in Urine

702

7079

0.99

0.09

3.8

3.5

65.15

46.99

mg/l

1.37

487

4684

(21491868) Cryoglobulin [Mass/volume] in Serum

1.07

0.08

1.2

1.3

—

0.06

g/l

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.03

0.08

1.0

1.2

—

16.25

—

(4015189) Microbial culture of sputum

0.82

0.08

1.8

2.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.81

0.08

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.86

0.07

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.81

0.07

1.2

38.97

38.85

g/l

—

(3003740) Influenza virus B Ag [Presence] in Specimen

147

1.09

0.07

1.1

—

(3006462) Nitrate [Presence] in Urine

1.05

0.07

2.7

3.8

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

767

7716

0.99

0.06

2.9

2.4

74.28

78.48

nmol/l

3.33

711

6752

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

226

1.06

0.06

3.8

3.9

—

(3002523) Influenza virus A Ag [Presence] in Specimen

148

1.08

0.06

1.1

—

(3017704) Immunofixation for Urine

111

0.90

0.06

1.0

1.2

—

(40768443) Skin Pathology biopsy report

689

0.97

0.06

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

119

1.09

0.06

3.1

2.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

120

0.92

0.05

2.2

1.8

76.91

94.99

umol/l

1.22

120

(3003327) Ova and parasites identified in Stool by Light microscopy

444

0.97

0.04

1.7

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

190

0.95

0.04

1.3

—

(44806420) Estimation of glomerular filtration rate

142

1.06

0.02

3.6

2.6

—

(3023410) Appearance of Cerebral spinal fluid

143

1.05

0.01

1.5

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

169

1.01

0.00

1.1

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

100

1.00

0.00

1.0

1.2

111.30

141.99

nmol/l

—

100

(3032773) Endomysium IgG Ab [Titer] in Serum

133

0.98

0.00

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.00

0.00

1.2

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.85

0.00

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.88

-0.00

1.0

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

-0.00

0.0

3.0

—

44.40

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.2

—

7.98

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

-0.00

0.0

1.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.6

—

(3047189) Immunofixation for 24 hour Urine

0.93

-0.00

1.3

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.6

—

(4211845) Urine protein measurement

0.97

-0.00

2.7

3.7

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.2

—

1.24

—

(3042517) Benzodiazepines panel - Urine

0.00

-0.00

0.0

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

0.02

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

-0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

4.6

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.8

—

1.38

—

(3017509) Phencyclidine [Presence] in Urine

0.00

-0.00

0.0

1.7

—

(3022689) Creatine [Moles/volume] in Urine

0.91

-0.00

1.2

1.5

9.28

8.05

mmol/l

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.00

-0.00

0.0

6.0

—

11.00

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_BILIARY_GALLBLADDER – Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder (C3_BILIARY_GALLBLADDER)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints